Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nonsense-Mediated Decay Targeted RNA (ntRNA): Proposal of a ntRNA-miRNA-lncRNA Triple Regulatory Network Usable as Biomarker of Prognostic Risk in Patients with Kidney Cancer. | Genes (Basel) | 2022 | 36140823 | PubTator, text mining | PubMed |
| Investigating the Role of Circulating miRNAs as Biomarkers in Colorectal Cancer: An Epidemiological Systematic Review. | Biomedicines | 2022 | 36140324 | PubTator, text mining | PubMed |
| Understanding the Role of GLUT2 in Dysglycemia Associated with Fanconi-Bickel Syndrome. | Biomedicines | 2022 | 36140215 | PubTator, text mining | PubMed |
| Mechanisms Controlling MicroRNA Expression in Tumor. | Cells | 2022 | 36139427 | PubTator, text mining | PubMed |
| Targeting Gastric Cancer Stem Cells to Enhance Treatment Response. | Cells | 2022 | 36139403 | PubTator, text mining | PubMed |
| p53: From Fundamental Biology to Clinical Applications in Cancer. | Biology (Basel) | 2022 | 36138802 | PubTator, text mining | PubMed |
| The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma. | Cancer Manag Res | 2022 | 36133739 | PubTator, text mining | PubMed |
| Advances in vitiligo: Update on therapeutic targets. | Front Immunol | 2022 | 36119071 | PubTator, text mining | PubMed |
| The diagnostic and prognostic value of the miR-17-92 cluster in hepatocellular carcinoma: A meta-analysis. | Front Genet | 2022 | 36118845 | PubTator, text mining | PubMed |
| Advances in multi-omics research on viral hepatitis. | Front Microbiol | 2022 | 36118247 | PubTator, text mining | PubMed |
| Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network. | Front Genet | 2022 | 36105104 | PubTator, text mining | PubMed |
| miR-22-3p as a potential biomarker for coronary artery disease based on integrated bioinformatics analysis. | Front Genet | 2022 | 36105099 | PubTator, text mining | PubMed |
| Differentially Expressed microRNAs in Peritoneal Dialysis Effluent-Derived Exosomes from the Patients with Ultrafiltration Failure. | Genet Res (Camb) | 2022 | 36101746 | PubTator, text mining | PubMed |
| m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease. | Front Cardiovasc Med | 2022 | 36093132 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments. | Front Cardiovasc Med | 2022 | 36082126 | PubTator, text mining | PubMed |
| Current Understanding of Asthma Pathogenesis and Biomarkers. | Cells | 2022 | 36078171 | PubTator, text mining | PubMed |
| Molecular Pathways in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2022 | 36077398 | PubTator, text mining | PubMed |
| miR-454-3p and miR-194-5p targeting cardiac sarcolemma ion exchange transcripts are potential noninvasive diagnostic biomarkers for childhood dilated cardiomyopathy in Egyptian patients. | Egypt Heart J | 2022 | 36076093 | PubTator, text mining | PubMed |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. | Cell Mol Biol Lett | 2022 | 36064322 | PubTator, text mining | PubMed |
| MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma. | Front Genet | 2022 | 36061185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=27